[go: up one dir, main page]

AR048864A1 - Tabletas dispersables que comprenden un derivado de acido benzoico - Google Patents

Tabletas dispersables que comprenden un derivado de acido benzoico

Info

Publication number
AR048864A1
AR048864A1 ARP050101362A ARP050101362A AR048864A1 AR 048864 A1 AR048864 A1 AR 048864A1 AR P050101362 A ARP050101362 A AR P050101362A AR P050101362 A ARP050101362 A AR P050101362A AR 048864 A1 AR048864 A1 AR 048864A1
Authority
AR
Argentina
Prior art keywords
benzoic acid
acid derivative
available tablets
tablets
available
Prior art date
Application number
ARP050101362A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR048864A1 publication Critical patent/AR048864A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Tabletas dispersables que comprenden como ingrediente activo, ácido 4-[3,5-bis(2-hidroxifenil)-[1,2,4]triazol-1-il]benzoico, o una sal farmacéuticamente aceptable del mismo, en una cantidad de 5 a 40% en peso, basado en el peso total de la tableta. Procedimiento.
ARP050101362A 2004-04-08 2005-04-06 Tabletas dispersables que comprenden un derivado de acido benzoico AR048864A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0408078.4A GB0408078D0 (en) 2004-04-08 2004-04-08 Organic compounds

Publications (1)

Publication Number Publication Date
AR048864A1 true AR048864A1 (es) 2006-06-07

Family

ID=32320645

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101362A AR048864A1 (es) 2004-04-08 2005-04-06 Tabletas dispersables que comprenden un derivado de acido benzoico

Country Status (14)

Country Link
US (1) US20080312302A1 (es)
EP (1) EP1734924A1 (es)
JP (1) JP2007532509A (es)
CN (1) CN1997348A (es)
AR (1) AR048864A1 (es)
AU (2) AU2005230402A1 (es)
BR (1) BRPI0509645A (es)
CA (1) CA2559739A1 (es)
GB (1) GB0408078D0 (es)
PA (1) PA8629501A1 (es)
PE (1) PE20060717A1 (es)
RU (1) RU2396954C2 (es)
TW (1) TW200603841A (es)
WO (1) WO2005097062A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007051773A1 (en) * 2005-11-01 2007-05-10 Novartis Ag Method of scintigraphy
MX2008014292A (es) 2006-05-09 2008-11-18 Novartis Ag Combinacion que comprende un quelante de hierro y un agente anti-neoplastico, y uso de la misma.
DK2026801T3 (da) * 2006-05-23 2014-01-27 Novartis Ag Deferasirox til behandling af arvelig hæmochromatose
KR20150046369A (ko) 2006-11-29 2015-04-29 노파르티스 아게 데페라시록스 (ｉｃｌ６７０ａ)의 다형체 형태
JPWO2010032489A1 (ja) 2008-09-22 2012-02-09 国立大学法人旭川医科大学 鉄キレート剤及びその製造方法、並びに鉄イオンの定量・捕捉方法
EA201390079A1 (ru) * 2010-07-08 2013-09-30 Рациофарм Гмбх Пероральная лекарственная форма деферазирокса
CA2812505A1 (en) 2010-10-01 2012-04-05 Cipla Limited Pharmaceutical composition
WO2012096183A1 (ja) 2011-01-14 2012-07-19 株式会社ダステック 高分子鉄キレート剤
WO2014072673A1 (en) 2012-11-12 2014-05-15 Cipla Limited Fixed dose pharmaceutical composition comprising deferasirox and deferipone
KR20170045391A (ko) * 2013-03-08 2017-04-26 노파르티스 아게 데페라시록스의 경구 제제
MX2015015553A (es) 2013-05-10 2016-06-17 Cipla Ltd Composicion farmceutica de dosis baja.
ES2734675T3 (es) 2014-05-20 2019-12-11 Sanovel Ilac Sanayi Ve Ticaret As Formulación de comprimido dispersable en agua que contiene deferasirox
EP2987482A1 (en) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Soluble and dispersible pharamaceutical deferasirox formulation
WO2016167729A1 (en) 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Dispersible tablets comprising deferasirox
WO2018007956A1 (en) * 2016-07-05 2018-01-11 Jubilant Generics Limited Immediate release pharmaceutical composition of iron chelating agents
EP3518904A1 (en) 2016-09-30 2019-08-07 Synthon B.V. Pharmaceutical composition comprising deferasirox
CZ2017255A3 (cs) 2017-05-04 2018-11-14 Zentiva, K.S. Filmem potažené tablety Deferasiroxu
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
EP3675832A1 (en) 2017-09-01 2020-07-08 Jordan Sweden Medical and Sterilization Company Fast self dispersible dosage forms of deferasirox
TR201722910A2 (tr) 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
DE4412117A1 (de) * 1994-04-08 1995-10-12 Fette Wilhelm Gmbh Verfahren und Vorrichtung zum Aufbringen von pulverförmigem Schmier- oder Trennmittel auf die Preßwerkzeuge in Tablettiermaschinen
MY129541A (en) * 1996-06-25 2007-04-30 Novartis Ag Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
JP2002505269A (ja) * 1998-03-06 2002-02-19 エウランド インターナショナル ソシエタ ペル アチオニ 急速崩壊錠剤
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US7961712B2 (en) * 2000-05-08 2011-06-14 Broadcom Corporation System and method for supporting multiple voice channels
RU2003129506A (ru) * 2001-03-06 2005-03-10 Киова Хакко Когио Ко., Лтд. (Jp) Быстрораспадающаяся во рту таблетка
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound

Also Published As

Publication number Publication date
RU2006139000A (ru) 2008-05-20
WO2005097062A1 (en) 2005-10-20
BRPI0509645A (pt) 2007-09-18
US20080312302A1 (en) 2008-12-18
AU2005230402A1 (en) 2005-10-20
CN1997348A (zh) 2007-07-11
AU2009201696A1 (en) 2009-05-21
EP1734924A1 (en) 2006-12-27
PA8629501A1 (es) 2005-11-25
TW200603841A (en) 2006-02-01
CA2559739A1 (en) 2005-10-20
GB0408078D0 (en) 2004-05-12
JP2007532509A (ja) 2007-11-15
PE20060717A1 (es) 2006-08-02
RU2396954C2 (ru) 2010-08-20

Similar Documents

Publication Publication Date Title
PA8586501A1 (es) Tabletas dispersables que comprenden un derivado de acido benzoico
AR048864A1 (es) Tabletas dispersables que comprenden un derivado de acido benzoico
AR039335A1 (es) Tableta de carga de droga alta
ECSP066807A (es) Formulaciones galénicas de compuestos orgánicos
ECSP088379A (es) Tabletas dispersables que comprenden deferasirox
CL2011000642A1 (es) Unidad de dosificacion que comprende 25 a 400 mg del acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico; kit farmaceutico que comprende la unidad de dosificacion; y su uso para el tratamiento de fibrosis quistica.
EA201070588A1 (ru) Производные 1,2,3-триазола для применения в качестве ингибиторов стеароил-соа десатуразы
CO6450624A2 (es) Compuestos vinil indazolilo
ECSP12011699A (es) Tableta
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
WO2008074832A3 (en) Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd)
WO2008065144A3 (en) Galenic formulations of organic compounds
MX2010003260A (es) Formulaciones galenicas de alisquireno.
UY29403A1 (es) Composiciones farmacéutica sólida que comprende telitromicina.
PE20070012A1 (es) Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil) ftalazin-1-ilo] micronizado, y sus sales
CR7539A (es) Tableta con alto contenido de farmacos
TW200607498A (en) Agents for prevention or treatment of diseases associated with endothelial hyperproliferation
TH102392A (th) การดำเนินการให้ของสารยับยั้งไดเปปติดิล เปปติเดส
TH118221A (th) สูตรผสมกาเลนนิคัลของสารประกอบอินทรีย์
TH79600A (th) รูปแบบยาของแข็งที่ให้ทางปากที่มีขนาดของเอสตราไดออลต่ำ
TH103172A (th) ยาผสมตามสูตรมาตรฐานของสารประกอบอินทรีย์

Legal Events

Date Code Title Description
FB Suspension of granting procedure